Introduction
Tuberculosis (TB) is a major public health problem globally (Nunn, 2001) . Approximately one-third of the world's population is infected with the bacterium, Mycobacterium tuberculosis, that causes TB. This makes TB a significant cause of morbidity/mortality, as it results in approximately 2 million deaths annually (Dye et al., 1999) . However, only 10% of those infected are estimated to progress to active TB disease. Host genetic factors are important determinants of susceptibility to tuberculosis (Casanova and Abel, 2002) . The doubly high risk of disease in identical twins compared with nonidentical twins (Comstock, 1978) indicates a host genetic component in susceptibility. Understanding the molecular mechanisms underlying protective immunity is a prerequisite for the development of improved therapies and vaccines for tuberculosis.
It is likely that host susceptibility to TB is at least partly under polygenic control. Previous genetic studies have reported that the major histocompatibility complex (MHC) genes have a role in influencing resistance and susceptibility to TB in human populations (Thursz et al., 1995 , Ghosh et al., 2004 . More recent reports have also identified a number of non-MHC gene polymorphisms that are associated with resistance or susceptibility to TB, including the natural resistance associated with the macrophage protein (NRAMP1) and the vitamin D receptor genes (VDR) .
IL10 is a powerful TH2-cell cytokine produced by lymphoid cells that exerts its function by inhibiting macrophage/monocyte and T-cell lymphocyte replication and secretion of inflammatory cytokines (Redpath et al., 2001; Choi et al., 2003) . Two SNPs in the promoter region, IL10 -1082 A G and -592 A C, are particularly interesting, because several previous reports have demonstrated quantitative differences in IL10 transcription and/or expression mediated by alternative alleles or haplotypes. Differences in nuclearbinding activity and IL10 production mediated by the IL10 -592 A C polymorphism (Rosenwasser and Borish, 1997; Shin et al., 2000) have also been reported.
In this study, one promoter SNP in IL10 is shown to be associated with the decreased risk of TB through examination of a large number of patients with clinical TB infection (n = 459) and normal controls (n = 871) recruited from the Korean population.
M aterials and M ethods
Study subjects A total of 459 patients with clinical pulmonary tuberculosis (mean age, 46.9 years; range, 18-86 years) were recruited from the Clinical Research Center for Tuberculosis, National Masan Tuberculosis Hospital, Korea. The diagnosis of pulmonary tuberculosis was confirmed by the isolation of acid fast bacilli (AFB) from sputum or bronchoalveolar lavage fluid. TB patients who had a family history of the Com m on interleukin 10 polym orphism associated with decreased risk of tuberculosis disease were also excluded to eliminate the additional risk factors of exposure to TB. A total of 871 healthy controls (mean age, 56.1 years; range, 50-81 years) were simultaneously recruited from an unselected population who had come in for routine health checkups in the same regional area. Only subjects whose ages were greater than 50 were included in normal controls to exclude the possibility of TB infection among young individuals (TB may subsequently develop in a proportion of the controls). Individuals with other apparent disease such as HIV, hepatitis (mainly chronic hepatitis B infection), autoimmune diseases, diabetes, alcoholism, and cancers were excluded from the study (cases and controls). Ethnicity of all patients and controls was Korean. Informed consents were obtained from all subjects before drawing blood. The study protocol was approved by the Institutional Review Board of National Masan Hospital. Written informed consent was obtained from each subject.
G enotyping
The sequences of amplifying and extension primers for IL10 SNP genotyping of IL10 -1082 A G, IL10 -819 T C, IL10 -592 A C, and IL10 +117 T C are the following:
forward-5'-atagctgacccagcccctt-3', reverse-5'-aaatcgttcacagagaagctcagt-3', and extension-5'-gctcagtaaataaa ta ga a atg g g g g ttg a g g ta tc a g a g g ta a ta a a ta ttc ta t-3 ', respectively. Single-base extension methods were used for genotyping of SNPs in IL10 as described previously (Makridakis and Reichardt, 2001 ). Genotyping quality control was performed in 10% of samples by duplicate checking (rate of concordance in duplicates was 99%).
Statistics
Haplotypes of each individual were inferred using the algorithm developed by Stephens et al. (2001) (PHASE) . Logistic regression models were used for calculating odds ratios (95% confidential interval) and corresponding P-values, controlling for age (continuous value), sex (male = 0, female = 1), and smoking status (nonsmoker = 0, ex-smoker/smoker = 1) as covariates.
R esults
The frequencies of minor alleles of four IL10 SNPs were 0.07 (IL10 -1082 A G), 0.31 (IL10 -819 T C), 0.31 (IL10 -592 A C), and 0.03 (IL10 +117 T C), respectively, in the Korean population studied (n = 1,330). IL10 -819 T C was excluded from analysis because it was in absolute LD with IL10 -592 A C. Genotype distributions in all loci were in Hardy-W einberg equilibrium (P 0.05) (data not shown). 
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Note: Logistic regression models were used for calculating odds ratios (95% confidential interval), corresponding P-values for SNP sites and haplotypes, controlling for age, sex and smoking status as covariates. P-values of additive and dominant analyses are also given. IL10 -819T C was excluded in this further analysis because it was in absolute LD with IL10 -592A C. Only one haplotype (ht2) was analyzed because of equivalence of haplotypes 1 and 3 with IL10 -592 and IL10 +117, as well as relatively low frequency (ht4, freq = 0.038) ( Figure 1B ). Linkage disequilibrium analyses (|D| and r 2 ) among normal controls showed that all SNPs were tightly linked. *Minor allele frequencies, **Dominant analysis: homozygotes for the major allele vs. heterozygotes+homozygotes for the minor allele.
Four haplotypes were identified without any ambiguous phasing due to LDs among SNPs ( Figure 1B) . Only one haplotype (ht2) was analyzed due to the equivalence of haplotypes 1 and 3 with IL10 -592 and IL10 +117, respectively, as well as low frequency (ht4, freq = 0.038) ( Figure 1B ). Linkage disequilibrium analyses (|D| and r 2 ) among normal controls showed that all SNPs were tightly linked (Figure 1) . Logistic regression analyses controlling for age (continuous value), sex (m ale = 0, fem ale = 1), and smoking status (non-smoker = 0, ex-smoker/smoker = 1) as covariates revealed significant associations of IL10 -592 A C and one common (freq. = 0.24) haplotype (ht2[A-C-C-T]) with decreased risk of clinical tuberculosis disease. The frequency of -592C-bearing genotypes (AC or CC of IL10 -592 A C) was higher in normal controls (55.8%) than in patients (47.1%) (P = 0.005, OR = 0.69). Similar genetic effects from IL10-ht2, which was constructed from a combination of IL10 -1082 A G and -592 A C ( Figure 1B) , were also observed (P = 0.04, OR = 0.75) ( Table 2) .
In order to evaluate the genetic effect of IL10 -1082 A G, a nearby SNP in the promoter region, which has been controversial, we have compared the results of previous studies. We found that the frequencies of IL10 -1082 A G were much higher in Caucasian than in Asian (Korean) populations. Marginal associations had been reported in Cambodian (Delgado et al., 2002) and Italian populations (Scola et al., 2003) , whereas no significant associations in Spanish (Lopez-Maderuelo et al., 2003) , Gambian , and Korean populations (this study) have been found.
D iscussion
The World Health Organization (WHO) has estimated the incidence of TB (the number of new cases arising each year) to be more than 8.7 million, and that 2 million deaths resulted from TB in 2002 alone. HIV and TB form a lethal combination, each speeding the other's progress. HIV weakens the immune system; thus, someone who is HIV-positive and infected with TB is many times more likely to become sick with TB than someone infected with TB who is HIVnegative. TB is a leading cause of death among people who are HIV-positive. It accounts for about 13% of AIDS deaths worldwide. In Africa, HIV is the single most important factor contributing to the increased incidence of TB in the past 10 years (Please see http://www.who.int/mediacentre/factsheets/fs104/en/).
A puzzling feature of mycobacterial infection is that clinically evident disease occurs in only a small proportion of those who are infected. However, the mechanisms that distinguish a successful immune response from an ineffective response remain poorly understood. Familial clustering, racial differences in incidence, and twin studies suggest that genetic factors play a role in susceptibility (Comstock, 1978; , Fine, 1981) .
IL10, produced mainly by macrophages, acts as a potent immunosuppressive cytokine by down-regulating the expression of Th1 cytokines and co-stimulatory molecules (Redpath et al., 2001) . Several positive associations of IL10 polymorphisms with various infectious diseases have previously been detected (Opdal, 2004) . The genetic involvement of IL10 polymorphisms in infectious diseases, and TB in this study, suggest that IL10 polymorphisms play a critical role in immunity and in inflammation progress.
By screening a large number of TB patients in the Korean population, we are able to suggest, for the first time, that one IL10 promoter SNP (IL10 -592A C) and one common haplotype (ht2[A-C-C-T]) are significantly associated with decreased risk of clinical TB disease. When considering that IL10 -ht2 is mostly ( 93%) tagged by the C allele of IL10 -592 A C ( Figure 1B) , it seems very likely that the genetic effects of IL10-ht2 come from IL10 -592 A C. Although the protective mechanisms against clinical TB disease by increased IL10 are not fully understood, several clues were reported. Much higher serum IL10 was detected in patients with clinical TB (Barnes et al., 1993) , suggesting that IL10 plays a role in susceptibility to tuberculosis.
On the other hand, although the power to detect was relatively low (48% Table 2 ). The associations of IL10 -1082 A G have been examined previously in separate studies Delgado et al., 2002; Lopez-Maderuelo et al., 2003; Scola et al., 2003) . The previous researchers examined only the genetic effect of the IL10 -1082 A G polymorphism, and discrepancies were observed among these studies. Specifically, two positive (elgado et al., 2002; Scola et al., 2003) and two negative LopezMaderuelo et al., 2003) associations had been reported.
Although it is hard to decipher the discrepancies among studies on the effect of IL10 -1082 A G on TB, one possible explanation might be the low sample sizes (cases or controls) and/or marginal significances in two studies in which positive associations were detected, i.e., 462 subjects (356 cases vs. 106 controls, P = 0.03) (Delgado et al., 2002) and 159 subjects (45 cases vs. 114 controls, P = 0.05) (Scola et al., 2003) . Another possible explanation might be the different genetic and/or environmental backgrounds among populations. It is also worth noting that 1) allele frequencies of IL10 -1082G* were much higher in Caucasian (freq. 0.36) (Lopez-Maderuelo et al., 2003; Scola et al., 2003) than in Asian (Korean) populations (freq.= 0.07 in this study; results from Delgado et al. (2002) were excluded because severe deviation from HWE ( 0.0001), even in normal controls, was observed), and 2) complete LD (|D|=1 and r 2 1) was observed between IL10 -1082 A G and -592 A C.
In summary, one common promoter SNP (IL10 -592 A C) was found to have significant association with decreased risk of tuberculosis infection through screening of a large number of TB patients (n = 459) and normal controls (n = 871) recruited from the Korean population. The genetic effects of IL10 -1082 A G, which have been controversial, were also presented.
